Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model.

ABSTRACT:

SUBMITTER: Tavernari L 

PROVIDER: S-EPMC12618570 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature